We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Looking to Tap Into Private Drug Surveillance Registries
FDA Looking to Tap Into Private Drug Surveillance Registries
May 4, 2005
The FDA has started taking a closer look at using private drug surveillance databases, such as those maintained by health plans, to enhance its ability to monitor adverse drug events.